Prediabetic HbA1c and Cortical Atrophy: Underlying Neurobiology

Diabetes Care. 2023 Dec 1;46(12):2267-2272. doi: 10.2337/dc23-1105.

Abstract

Objective: To investigate the relationship between blood glycated hemoglobin (HbA1c) and cerebral cortical thickness (CT) and identify potential cellular mechanisms involved.

Research design and methods: A cohort of 30,579 adults age 45 to 81 (mean ± SD: 64 ± 7.5) years with available data on brain MRI and blood HbA1c levels was analyzed. The relationship between HbA1c and CT was probed using independent spatial profiles of cell-specific gene expression. Lastly, a genome-wide association study was conducted on the shared variance between HbA1c and CT.

Results: The HbA1c-CT association was noncontinuous, emerging negatively within the prediabetic range (39.6 mmol/mol). This association was strongest in brain regions with higher expression of genes specific to excitatory neurons and lower expression of genes specific to astrocytes and microglia. A significant locus implicated mitochondrial maintenance and ATP generation.

Conclusions: Effective glycemia control at prediabetic levels is warranted to preserve brain health and prevent prediabetes-related neurobiologic perturbations.

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Atrophy
  • Blood Glucose / metabolism
  • Genome-Wide Association Study
  • Glycated Hemoglobin
  • Humans
  • Middle Aged
  • Neurobiology
  • Prediabetic State* / genetics

Substances

  • Glycated Hemoglobin
  • Blood Glucose